Sartorius starts up operations at expanded site in Puerto Rico

Göttingen, Germany | Yauco, Puerto Rico – June 18, 2019 Investment of more than 100 million U.S. dollars Area designed for future growth After investing more than 100 million U.S. dollars, Sartorius, a leading international partner of biopharmaceutical research and the industry, started up its expanded manufacturing operations in Yauco, Puerto Rico. The U.S. market is... Read more

Datacolor Launches SpyderX Tool Kits for Digital Photographers

Lawrenceville, New Jersey, USA (June 18, 2019) – Datacolor®, a global leader in color management solutions, announced the launch of two new product bundles for photographers to manage their color workflow: SpyderX Capture Pro and SpyderX Studio. Both include the recently launched SpyderX color calibrator for monitors – the most accurate, fastest (4X faster) and easiest-to-use... Read more

Synergy and Cytation Readers Validated for Agilent MitoXpress and pH-Xtra Assays

June 18, 2019 BioTek is pleased to announce that its Synergy™ H1 and Synergy Neo2 Hybrid Multi-Mode Readers and its Cytation™ 1 and Cytation 5 Cell Imaging Multi-Mode Readers are validated for use with the MitoXpress and pH-Xtra Assays from Agilent Technologies. The assays may be used alone or combined to measure metabolism in live cells. Instructional Applications Bulletins are available for each multi-mode reader detailing the specific parameters... Read more

BD Unveils New Solution for High Throughput Molecular Diagnostic Testing

Automated BD COR™ System Achieves CE-IVD Status; Now Available in Europe Jun 18, 2019 FRANKLIN LAKES, NJ (June 18, 2019) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE-IVDD certification of the BD COR™ System in Europe. The high throughput solution for infectious disease diagnostics sets a new standard... Read more

New State-of-the-Art Facility Increases Agilent’s Capacity to Produce Nucleic Acid-Based Therapeutics

New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) today announced the opening of a production facility in Colorado that more than doubles its capacity to develop and manufacture “oligos,” which are short DNA and... Read more

Ontera Awarded ~$1M Contract from IARPA for Zika Genotyping Test

June 18, 2019 07:30 AM Eastern Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Ontera Inc., the leader in silicon-based nanopore diagnostics, announced today that the company has received a $982,593 contract from Intelligence Advanced Research Projects Activity (IARPA), part of the Office of the Director of National Intelligence that invests in research and innovative technologies to strengthen... Read more

IDEX Corporation Announces Appointment of Carl R. Christenson to Board of Directors

June 17, 2019 at 4:27 PM EDTPDF Version LAKE FOREST, Ill.–(BUSINESS WIRE)–Jun. 17, 2019– IDEX Corporation (NYSE:IEX) today announced the appointment of Carl R. Christenson to the company’s Board of Directors. The appointment of Mr. Christenson, effective immediately, increases the size of the Board from nine to ten directors. Mr. Christenson will serve on the Board’s Compensation... Read more

Grace Acquires the Business of Rive Technology, Inc.

COLUMBIA, Md., June 17, 2019 (GLOBE NEWSWIRE) — W. R. Grace & Co. (NYSE:GRA) today completed the acquisition of the business  and assets of Rive Technology, Inc., including its Molecular Highway™ zeolite technology. As part of the transaction, certain research and development, technical services, and commercial employees will join Grace. Financial details of the transaction... Read more

FDA Grants Breakthrough Device Designation to Bio-Techne’s ExoDx™ Prostate Intelliscore™ (EPI) Test

JUNE 17, 2019 MINNEAPOLIS, June 17, 2019 /PRNewswire/ — Bio-Techne today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ExoDx Prostate IntelliScore (EPI) test, making it the first exosome-based liquid biopsy test to receive a Breakthrough Device Designation. This designation not only validates the clinical importance of... Read more

Versum Stockholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

17 JUN 2019 | DARMSTADT, GERMANY Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its transaction with Versum Materials, Inc. (NYSE: VSM) was approved at a special meeting of Versum’s stockholders. On April 12, 2019, Merck KGaA, Darmstadt, Germany, had signed a definitive agreement to acquire Versum for US$53 per share in cash. “We... Read more